These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12125130)

  • 1. Peptide vaccination.
    Meraldi V; Romero JF; Corradin G
    Methods Mol Med; 2002; 72():335-45. PubMed ID: 12125130
    [No Abstract]   [Full Text] [Related]  

  • 2. Selecting candidate antigens for malaria vaccines.
    Kidson C; Saul A; Schofield L; Upcroft J; Don M; Read D; Myler P; Castelino D; Chiu S; Ingram L
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):325-8. PubMed ID: 6085274
    [No Abstract]   [Full Text] [Related]  

  • 3. The comparative immunobiology of Plasmodium: model systems and new technologies in malaria vaccine research.
    Mitchell GH
    Prog Vet Microbiol Immunol; 1987; 3():112-38. PubMed ID: 3078831
    [No Abstract]   [Full Text] [Related]  

  • 4. Limiting dilution analysis of antigen-specific CD4+ T-cell responses in mice.
    Seixas E; Langhorne J; Quin S
    Methods Mol Med; 2002; 72():385-99. PubMed ID: 12125134
    [No Abstract]   [Full Text] [Related]  

  • 5. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.
    Bejon P; Kai OK; Mwacharo J; Keating S; Lang T; Gilbert SC; Peshu N; Marsh K; Hill AV
    Eur J Immunol; 2006 Aug; 36(8):2264-72. PubMed ID: 16856208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccines blocking transmission].
    Sauerwein R
    Med Trop (Mars); 1995; 55(4 Suppl):118. PubMed ID: 8649254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malaria vaccines: prospects and reality].
    Rogier C; Orlandi-Pradines E; Fusaï T; Pradines B; Briolant S; Almeras L
    Med Mal Infect; 2006 Aug; 36(8):414-22. PubMed ID: 16949781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria: a protective paradox.
    Hoffman SL
    Nature; 2006 Dec; 444(7121):824-7. PubMed ID: 17151601
    [No Abstract]   [Full Text] [Related]  

  • 10. Malaria vaccines: if at first you don't succeed..
    Tongren JE; Zavala F; Roos DS; Riley EM
    Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apical membrane antigen 1: a malaria vaccine candidate in review.
    Remarque EJ; Faber BW; Kocken CH; Thomas AW
    Trends Parasitol; 2008 Feb; 24(2):74-84. PubMed ID: 18226584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprophylaxis of malaria: characterization of a protective surface antigen.
    Nussenzweig RS; Nussenzweig V
    Harvey Lect; 1982-1983; 78():59-85. PubMed ID: 6151556
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine development. Which way for malaria?
    Cox FE
    Nature; 1988 Feb; 331(6156):486-7. PubMed ID: 3124000
    [No Abstract]   [Full Text] [Related]  

  • 14. Parasitology. Malaria--from infants to genomics to vaccines.
    Long CA; Hoffman SL
    Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphatidylcholine liposomes as effective adjuvant for vaccination of mice against Plasmodium yoelii.
    Vinayak VK; Sharma R
    Indian J Med Res; 1986 Jul; 84():32-8. PubMed ID: 3770834
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
    Wang L; Goschnick MW; Coppel RL
    Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against malaria.
    Phillips RS
    Immunobiology; 1992 Feb; 184(2-3):240-62. PubMed ID: 1587546
    [No Abstract]   [Full Text] [Related]  

  • 18. Target antigens of malaria transmission blocking immunity.
    Kaushal DC; Carter R; Miller LH
    J Commun Dis; 1987 Dec; 19(4):417-21. PubMed ID: 3507450
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress towards a malaria vaccine.
    Ramasamy R
    Indian J Malariol; 1987 Jun; 24(1):1-7. PubMed ID: 3326750
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.